about
LeonaBio Inc is a clinical-stage biopharmaceutical company dedicated to the development of novel therapeutics for high unmet medical needs, including treatment-resistant metastatic breast cancer and amyotrophic lateral sclerosis (ALS).
Read More
5.57
-0.15
(-2.62%)
18,244
XNAS Volume
XNAS 03 Mar, 2026 4:30 PM (EST)
Board Meeting
The next board meeting for LeonaBio Inc is on 06 Mar 2026 for the purpose of LeonaBio Inc Fourth Quarter Earnings Results for 2025
See details
Not Eligible
Expensive Valuation
Technically Moderately Bullish
LeonaBio Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..